Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification

Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):88-9. doi: 10.1093/ehjcvp/pvv057. Epub 2016 Jan 27.

Authors

Farhan Shahid¹, Eduard Shantsila¹, Gregory Y H Lip²

Affiliations

¹ University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK.
² University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark g.y.h.lip@bham.ac.uk.

PMID: 27533519
DOI: 10.1093/ehjcvp/pvv057

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants*
Atrial Fibrillation*
Humans
Risk
Risk Assessment
Risk Factors
Stroke

Substances

Anticoagulants